調查批次:CHT2016-02 | 檢體寄出日期:2016-04-18 | 報告回收截止日期:2016-04-25 | 回收份數:12 |
TSH 檢驗院際品管調查結果: | ||
2.歷次品管檢體 TSH 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 4 |
1 |
3 |
13.8 |
0.1 |
0.7 |
0.1 |
0.6 |
3 |
23.3 |
1.3 |
5.9 |
0.7 |
0.8 |
25 |
RH07b | RH07 | 8 |
1 |
3 |
13.7 |
0.0 |
0.0 |
0.0 |
0.4 |
0 |
22.8 |
0.8 |
3.6 |
0.5 |
0.3 |
15 |
RH14 | RH14 | 7 |
1 |
3 |
12.9 |
-0.8 |
-5.8 |
-0.7 |
-1.1 |
-24 |
20.2 |
-1.8 |
-8.2 |
-1.0 |
-1.9 |
-34 |
RH15 | RH15 | 7 |
1 |
3 |
12.9 |
-0.8 |
-5.8 |
-0.7 |
-1.1 |
-24 |
22.3 |
0.3 |
1.4 |
0.2 |
-0.1 |
6 |
CL009 | CL009 | 3 |
1 |
3 |
13.3 |
-0.4 |
-2.9 |
-0.4 |
-0.4 |
-12 |
22.6 |
0.6 |
2.7 |
0.3 |
0.2 |
11 |
CL010 | CL010 | 3 |
1 |
3 |
13.7 |
0.0 |
0.0 |
0.0 |
0.4 |
0 |
25.3 |
3.3 |
15.0 |
1.9 |
2.5 |
63 |
CL012 | CL012 | 7 |
1 |
3 |
13.2 |
-0.5 |
-3.6 |
-0.5 |
-0.6 |
-15 |
21.2 |
-0.8 |
-3.6 |
-0.5 |
-1.0 |
-15 |
CL013 | CL013 | 4 |
1 |
5 |
11.6 |
1.9 |
19.6 |
2.4 |
- |
81 |
20.3 |
4.7 |
30.1 |
3.8 |
- |
125 |
CL014a | CL014 | 4 |
1 |
3 |
13.9 |
0.2 |
1.5 |
0.2 |
0.7 |
6 |
22.3 |
0.3 |
1.4 |
0.2 |
-0.1 |
6 |
CL015 | CL015 | 4 |
1 |
3 |
14.3 |
0.6 |
4.4 |
0.5 |
1.5 |
18 |
22.2 |
0.2 |
0.9 |
0.1 |
-0.2 |
4 |
Median of RIA Group |
- |
- |
||||||||||||||
Range of RIA Group |
11.6 - 14.3 |
20.2 - 25.3 |
||||||||||||||
Robust mean of RIA Group |
- ( n = 1 ) |
- ( n = 1 ) |
||||||||||||||
Robust SD of RIA Group |
- |
- |
||||||||||||||
CV of RIA Group |
0.0% |
0.0% |
||||||||||||||
Median of European RIA Labs |
10.6 ( n = 107 ) |
15.8 ( n = 106 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
9.7 - 12.7 |
14.8 - 20.7 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 1 |
3 |
9 |
9.3 |
-0.4 |
-4.1 |
-0.5 |
0.0 |
-17 |
14.4 |
-1.2 |
-7.7 |
-1.0 |
-0.1 |
-32 |
RH02c | RH02 | 2 |
3 |
1 |
7.8 |
-1.9 |
-19.6 |
-2.4 |
-1.6 |
-81 |
12.5 |
-3.1 |
-19.9 |
-2.5 |
-1.4 |
-83 |
RH06 | RH06 | 1 |
3 |
9 |
9.3 |
-0.4 |
-4.1 |
-0.5 |
0.0 |
-17 |
14.4 |
-1.2 |
-7.7 |
-1.0 |
-0.1 |
-32 |
RH07a | RH07 | 3 |
3 |
2 |
8.4 |
-1.3 |
-13.4 |
-1.7 |
-1.0 |
-56 |
12.8 |
-2.8 |
-17.9 |
-2.2 |
-1.2 |
-75 |
RH12 | RH12 | 4 |
3 |
2 |
10.6 |
0.9 |
9.3 |
1.2 |
1.4 |
38 |
16.0 |
0.4 |
2.6 |
0.3 |
0.9 |
11 |
RH19 | RH19 | 1 |
3 |
2 |
9.6 |
-0.1 |
-1.0 |
-0.1 |
0.3 |
-4 |
16.4 |
0.8 |
5.1 |
0.6 |
1.2 |
21 |
RH20 | RH20 | 7 |
3 |
7 |
9.1 |
-0.6 |
-6.2 |
-0.8 |
-0.2 |
-26 |
14.1 |
-1.5 |
-9.6 |
-1.2 |
-0.3 |
-40 |
CL005 | CL005 | 2 |
3 |
9 |
9.8 |
0.1 |
1.0 |
0.1 |
0.5 |
4 |
15.3 |
-0.3 |
-1.9 |
-0.2 |
0.5 |
-8 |
CL006a | CL006 | 4 |
3 |
7 |
8.5 |
-1.2 |
-12.4 |
-1.5 |
-0.9 |
-51 |
13.4 |
-2.2 |
-14.1 |
-1.8 |
-0.8 |
-59 |
CL008 | CL008 | 4 |
3 |
2 |
10.4 |
0.7 |
7.2 |
0.9 |
1.2 |
30 |
15.0 |
-0.6 |
-3.8 |
-0.5 |
0.3 |
-16 |
CL011 | CL011 | 1 |
3 |
13 |
9.9 |
0.2 |
2.1 |
0.3 |
0.6 |
9 |
16.2 |
0.6 |
3.8 |
0.5 |
1.1 |
16 |
Median of CLIA Group |
9.3 |
14.4 |
||||||||||||||
Range of CLIA Group |
7.8 - 10.6 |
12.5 - 16.4 |
||||||||||||||
Robust mean of CLIA Group |
9.3 ( n = 11 ) |
14.6 ( n = 11 ) |
||||||||||||||
Robust SD of CLIA Group |
0.94 |
1.51 |
||||||||||||||
CV of CLIA Group |
10.1% |
10.3% |
||||||||||||||
Median of European CLIA Labs |
9.6 ( n = 1239 ) |
15.6 ( n = 1203 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
8.5 - 10.2 |
13.0 - 16.7 |
||||||||||||||
Median of All Labs |
9.5 |
14.7 |
||||||||||||||
Range of All Labs |
7.8 - 14.3 |
12.5 - 25.3 |
||||||||||||||
Robust mean of All Labs |
9.5 ( n = 12 ) |
14.8 ( n = 12 ) |
||||||||||||||
Robust SD of All Labs |
1.08 |
1.71 |
||||||||||||||
CV of All Labs |
11.4% |
11.6%
|
||||||||||||||
Median of All European Labs ( Xa ) |
9.7 |
15.6 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
8.5 - 10.3 |
13.1 - 16.9 |
||||||||||||||
Mean of All European Labs |
9.6 ( n = 1443 ) |
15.4 ( n = 1430 ) |
||||||||||||||
SD of All European Labs |
1.15 |
2.06 |
||||||||||||||
CV of All European Labs |
12.0% |
13.4% |
||||||||||||||
SD for proficiency
assessment ( σp ) |
0.776 |
1.248 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Sandwich-type ) |
1 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL014a, CL015, |
Chemiluminescent Immunoassay ( Sandwich-type ) |
3 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL014a, CL015, |
Immunotech |
5 |
CL013, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2016-11-08